ArticleThe oncologist2026

Conversion-intent PD-1-based chemoimmunotherapy restores surgical feasibility in borderline resectable or unresectable non-head-and-neck cutaneous squamous cell carcinoma.

Wenkang Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.